On July 30, 2025, the U.S. Food and Drug Administration (FDA) sent a notice requesting nominations for voting members to serve on the Tobacco Products Scientific Advisory Committee (TPSAC) by Aug. 25, 2025. Individuals may self-nominate or be nominated by any interested person or organization. TPSAC advises FDA in its responsibilities related to the regulation of tobacco products, such as any application submitted by a manufacturer for a modified risk tobacco product. The committee reviews and evaluates safety, dependence and health issues concerning tobacco products and provides appropriate advice, information and recommendations to the FDA commissioner.

Specifically, TPSAC is seeking to fill five vacancies with physicians, dentists, scientists or health care professionals practicing in oncology, pulmonology, cardiology, toxicology, pharmacology, addiction, engineering or any other relevant specialty. Included in the five vacancies is one vacancy for a representative of the general public, and one vacancy for an employee of federal, state or local government. Selected members will be invited to serve for terms of up to four years, which will begin on Feb. 1, 2026, after the current members’ terms expire. Read more here.